Andersen M - Search Results

1

Evaluating pharmacokinetic and pharmacodynamic interactions with computational models in supporting cumulative risk assessment.

Tan YM, Clewell H, Campbell J, Andersen M. Tan YM, et al. Among authors: andersen m. Int J Environ Res Public Health. 2011 May;8(5):1613-30. doi: 10.3390/ijerph8051613. Epub 2011 May 19. Int J Environ Res Public Health. 2011. PMID: 21655141 Free PMC article. Review.

2

Bayesian estimation of pharmacokinetic and pharmacodynamic parameters in a mode-of-action-based cancer risk assessment for chloroform.

Liao KH, Tan YM, Conolly RB, Borghoff SJ, Gargas ML, Andersen ME, Clewell HJ 3rd. Liao KH, et al. Risk Anal. 2007 Dec;27(6):1535-51. doi: 10.1111/j.1539-6924.2007.00987.x. Risk Anal. 2007. PMID: 18093051

3

On the incorporation of chemical-specific information in risk assessment.

Clewell HJ 3rd, Andersen ME, Blaauboer BJ. Clewell HJ 3rd, et al. Toxicol Lett. 2008 Aug 15;180(2):100-9. doi: 10.1016/j.toxlet.2008.06.002. Epub 2008 Jun 8. Toxicol Lett. 2008. PMID: 18588959 Review.

4

Multi-dose-route, multi-species pharmacokinetic models for manganese and their use in risk assessment.

Andersen ME, Dorman DC, Clewell HJ 3rd, Taylor MD, Nong A. Andersen ME, et al. J Toxicol Environ Health A. 2010;73(2):217-34. doi: 10.1080/15287390903340849. J Toxicol Environ Health A. 2010. PMID: 20077292

5

Physiologically based pharmacokinetic/toxicokinetic modeling.

Campbell JL Jr, Clewell RA, Gentry PR, Andersen ME, Clewell HJ 3rd. Campbell JL Jr, et al. Methods Mol Biol. 2012;929:439-99. doi: 10.1007/978-1-62703-050-2_18. Methods Mol Biol. 2012. PMID: 23007440

6

Development of PBPK models for PFOA and PFOS for human pregnancy and lactation life stages.

Loccisano AE, Longnecker MP, Campbell JL Jr, Andersen ME, Clewell HJ 3rd. Loccisano AE, et al. J Toxicol Environ Health A. 2013;76(1):25-57. doi: 10.1080/15287394.2012.722523. J Toxicol Environ Health A. 2013. PMID: 23151209 Free PMC article.

7

PBPK-Based Probabilistic Risk Assessment for Total Chlorotriazines in Drinking Water.

Breckenridge CB, Campbell JL, Clewell HJ, Andersen ME, Valdez-Flores C, Sielken RL Jr. Breckenridge CB, et al. Toxicol Sci. 2016 Apr;150(2):269-82. doi: 10.1093/toxsci/kfw013. Epub 2016 Jan 21. Toxicol Sci. 2016. PMID: 26794141 Free PMC article.

8

Incorporation of in vitro metabolism data and physiologically based pharmacokinetic modeling in a risk assessment for chloroprene.

Clewell HJ 3rd, Campbell JL, Van Landingham C, Franzen A, Yoon M, Dodd DE, Andersen ME, Gentry PR. Clewell HJ 3rd, et al. Among authors: andersen me. Inhal Toxicol. 2019 Nov-Dec;31(13-14):468-483. doi: 10.1080/08958378.2020.1715513. Epub 2020 Jan 28. Inhal Toxicol. 2019. PMID: 31992090

9

Application of a combined aggregate exposure pathway and adverse outcome pathway (AEP-AOP) approach to inform a cumulative risk assessment: A case study with phthalates.

Clewell RA, Leonard JA, Nicolas CI, Campbell JL, Yoon M, Efremenko AY, McMullen PD, Andersen ME, Clewell HJ 3rd, Phillips KA, Tan YM. Clewell RA, et al. Among authors: andersen me. Toxicol In Vitro. 2020 Aug;66:104855. doi: 10.1016/j.tiv.2020.104855. Epub 2020 Apr 8. Toxicol In Vitro. 2020. PMID: 32278033 Free PMC article.

10

Physiologically based pharmacokinetic model for the inhibition of acetylcholinesterase by organophosphate esters.

Gearhart JM, Jepson GW, Clewell HJ, Andersen ME, Conolly RB. Gearhart JM, et al. Among authors: andersen me. Environ Health Perspect. 1994 Dec;102 Suppl 11(Suppl 11):51-60. doi: 10.1289/ehp.94102s1151. Environ Health Perspect. 1994. PMID: 7737042 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,340 results

Search Page